UK BMT Pharmacists’ Group – Educational Meeting 5th March 2021

The UK BMT Pharmacists’ Group (a special-interest group affiliated to BOPA) is running an educational meeting via Zoom on the afternoon of Friday 5th March. The meeting will run from 1-5pm and the programme has been split into 4 x 1 hour slots to make it easy to dip in and out! Although the meeting will have a transplant-focus, the agenda has been made deliberately broad, and all pharmacists with an interest in haematology are very welcome to attend for some or all of the sessions. There is no registration fee and no need to pre-register.

 

The meeting agenda and all the details you need to log in can be found here: https://www.bopa.org.uk/bmtmeeting/

 

If you have any enquiries about the meeting please contact Nick Duncan at [email protected]

 

 

Latest News

By BOPA Research Committee on 25th April 2024

Survey: Pharmacogenomic Panel Testing in Cancer: UK Oncology Professionals

Please consider completing our BOPA member survey on the use of pharmacogenomic panel testing in people with solid tumours. Survey information I’m a pharmacist and pre-doctoral research fellow researching the…

Read article
By BOPA Research committee on 25th April 2024

NIHR Associate Principal Investigator (PI) Scheme is continuing to host Research Learning Lectures

The NIHR Associate Principal Investigator (PI) Scheme is continuing to host the Research Learning Lectures; a series of lectures for anyone in Health and Social Care interested in learning more about research.…

Read article
By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article